HCA Healthcare (NYSE:HCA) Given New $520.00 Price Target at Oppenheimer

HCA Healthcare (NYSE:HCA) had its price objective cut by Oppenheimer from $540.00 to $520.00 in a research note published on Monday, Marketbeat Ratings reports. They currently have an outperform rating on the stock.

A number of other equities analysts also recently commented on the stock. Mizuho increased their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Truist Financial cut their price objective on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday. Robert W. Baird dropped their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Finally, Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $523.09.

HCA Healthcare Stock Performance

NYSE:HCA opened at $446.38 on Monday. HCA Healthcare has a 52-week low of $326.14 and a 52-week high of $556.52. The stock has a 50-day simple moving average of $503.58 and a 200 day simple moving average of $486.01. The company has a market cap of $99.80 billion, a PE ratio of 15.35, a PEG ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the business earned $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.99%.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 in the last ninety days. 1.50% of the stock is currently owned by company insiders.

Institutional Trading of HCA Healthcare

Several large investors have recently modified their holdings of HCA. Cerity Partners LLC lifted its stake in HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after purchasing an additional 5,092 shares during the last quarter. National Pension Service lifted its position in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after buying an additional 17,531 shares during the last quarter. Savant Capital LLC raised its stake in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Sector Gamma AS boosted its stake in shares of HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after purchasing an additional 2,883 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after purchasing an additional 108,849 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Management reaffirmed FY2026 guidance and expects 2%–3% volume growth while acknowledging headwinds, which supports the company’s forward earnings outlook. HCA projects 2%-3% volume growth
• Positive Sentiment: HCA says improvements in its revenue‑cycle operations are boosting cash collections and helping offset rising denials/underpayments — a near‑term margin and cash‑flow positive. Revenue cycle paying dividends
• Positive Sentiment: Leadership hire: Cynthia Cifuentes‑Finkel will become SVP of Marketing & Corporate Affairs (effective June 8), adding senior marketing/communications capacity ahead of growth initiatives. HCA names new SVP
• Neutral Sentiment: Local operations: a new HCA Florida Gainesville hospital is preparing to open next month — incremental local growth but limited immediate impact on enterprise results. Gainesville hospital opening
• Neutral Sentiment: Market commentary pieces and index signals are discussing healthcare positioning; useful for macro context but not company‑specific catalysts. Market update
• Negative Sentiment: Multiple analysts reduced price targets and trimmed forecasts after Q1 results (despite an in‑line EPS), signaling more cautious near‑term sentiment. Firms lowering targets include Stephens, Oppenheimer, TD Cowen, Leerink, RBC and Truist. Analysts slash forecasts
• Negative Sentiment: Q1 dynamics: EPS roughly in‑line but seasonal volume softness, shifting payer mix and projected ACA/exchange pressures (company cites a $600M–$900M headwind range) are weighing on near‑term revenue and margin expectations. Q1 deep dive
• Negative Sentiment: Financing: HCA filed a proposed public offering of senior notes to raise proceeds for general corporate purposes (may include refinancing). New debt issuance could modestly pressure credit metrics depending on size and terms. Proposed senior notes offering

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.